KnowledgeScan logo

KnowledgeScan

Target Safety Assessments combining automated data mining, expert curation, and translational informatics for drug discovery decision-making.

Solution by Instem
Visit website

Overview

KnowledgeScan™ is a specialized Target Safety Assessment (TSA) service from Instem, designed to accelerate and improve decision-making in drug research and development. By combining a translational informatics platform, automated data mining, and expert human review, KnowledgeScan delivers robust, comprehensive, and reproducible TSAs that replace time-consuming and often incomplete manual literature reviews. It is intended for drug discovery teams, safety professionals, and research organizations seeking faster, more confident go/no-go decisions on biological targets.

The service is highly flexible and can be applied at any stage of the drug discovery process — from evaluating potential candidates to investigating unexpected preclinical findings. KnowledgeScan is offered in two tiers, a Full TSA and a Core TSA, allowing clients to select the level of assessment that best fits their specific needs and internal resources.

Key Benefits

  • Saves Time: Automated data mining streamlines literature reviews, reducing manual effort and accelerating target safety assessments so researchers can focus on decision-making rather than data gathering.
  • Reduced Bias: Systematic, automated workflows eliminate human bias, delivering an impartial and comprehensive view of target-related safety across vast literature and toxicology datasets.
  • Removes Risk: Thorough safety profiling and expert interpretation reduce the chance of overlooking critical toxicology signals, helping to de-risk drug discovery efforts early and safeguard regulatory submissions.
  • Increases Quality: Every report is curated and validated by scientific experts, ensuring high-quality, accurate insights to support decision-making in drug development.
  • Expedites Development: Faster, standardized TSAs shorten the time from target selection to go/no-go decisions, helping accelerate drug candidate progression through development pipelines.

Core Features

  • Powerful Visualizations: Easy-to-read plots help researchers quickly interpret large volumes of bioinformatics, pharmacology, and toxicology data to support faster, more confident decisions.
  • Transparent Methodology: Every step in the assessment process is fully traceable and reproducible, simplifying internal reviews and regulatory submissions.
  • Knowledge Gaps Identified: The platform identifies missing or underrepresented areas in the data, helping teams plan follow-up research and reduce uncertainty in target assessments.
  • Pharmacology Review: Analyzes known drug-target interactions, ligand activity, and pharmacodynamic data to predict how modulating a target may affect biological systems.
  • Physiological Review: Evaluates a target's function in both healthy and disease states to help researchers understand the full biological impact of therapeutic intervention.
  • Toxicology and Safety Alerts: Automatically highlights relevant toxicity signals and safety alerts from trusted literature and data sources to support early risk mitigation.
  • Bioinformatics Review: Processes genomic and proteomic data to uncover critical patterns, associations, and unintended target effects.
  • Systematic Anatomical Review: Reviews target expression across tissues and organs to flag site-specific risks and refine candidate selection strategies.

How KnowledgeScan Works

  1. Consultation: The process begins with a collaborative discussion to help Instem understand client priorities and define the project scope.
  2. Knowledge Acquisition: Using advanced data-mining tools, Instem extracts and refines millions of data points from published sources across pharmacology, bioinformatics, and toxicology.
  3. Curation: Expert scientists classify, tag, and further refine the data to ensure accuracy, relevance, and scientific integrity.
  4. Interpretation (Full TSA): The team analyzes and discusses the toxicological significance of findings, drawing evidence-based conclusions to guide decision-making.
  5. Continuous Updates (Full TSA): Clients can opt into Evergreen updates to receive regular reports as new internal and external data emerges.

Customer Success: Haisco Pharmaceutical Group

  • Haisco Pharmaceutical Group needed to streamline its TSA process to support rapid R&D decisions, but limited published data on novel targets made safety analysis time-consuming and resource-intensive.
  • By partnering with Instem and implementing KnowledgeScan, Haisco combined automated data mining, expert review, and standardized reporting to complement its in-house capabilities.
  • Results included significantly accelerated TSA production, improved evidence-based decision-making through comprehensive curated reports, and optimized use of internal resources by freeing scientists from manual data searches. A separate client case study reported a 400% increase in annual TSA throughput following outsourcing to KnowledgeScan.

KnowledgeScan is delivered as a fully outsourced service — clients submit their target of interest and Instem's team returns a comprehensive, standardized assessment report. Reports can complement in-house assessments or serve as a complete outsourced solution. Clients receive ongoing access to scientific experts, including post-report discussions, and can opt into Evergreen updates for continuous data monitoring. The service supports regulatory confidence through reproducible workflows and transparent, expert-validated methodologies.

Meta

Domain
Research Intelligence & Discovery
Subdomain
Scientific Literature Mining & Knowledge Discovery
Software type(s)
Analytical Platform
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
Academic / ResearchBiotechCROPharma
Development stage(s)
Research & DiscoveryPreclinical / Pre-Market
Target user(s)
Research ScientistBioinformatician / Computational ScientistQA / Regulatory Affairs